Trial Profile


Phase of Trial: Phase II

Latest Information Update: 04 Sep 2006

At a glance

  • Drugs Irbesartan (Primary)
  • Indications Stroke
  • Focus Pharmacodynamics
  • Acronyms ARS
  • Sponsors Sanofi-Synthelabo
  • Most Recent Events

    • 04 Sep 2006 The expected completion date for this trial is now 1 Feb 2007.
    • 04 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top